Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Astera LabsALAB | Open-market sale10b5-1 plan | 06/24 | 06/26 | 686 sh6 trades | $395.04avg. | $270,998.66 | −11.0% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 06/04 | 06/08 | 10,000 sh18 trades | $355.17avg. | $3,551,698.31 | −11.7% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 06/03 | 06/05 | 12,499 sh6 trades | $364.35avg. | $4,554,044.27 | No record | |
Philip MazzaraGeneral Counsel and Secretary | Astera LabsALAB | Open-market sale | 05/21 | 05/26 | 796 sh | $291.03 | $231,659.88 | −0.8% |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/21 | 05/26 | 400,000 sh5 trades | $290.30avg. | $116,120,928.92 | −7.3% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/19 | 05/21 | 280,000 sh6 trades | $249.19avg. | $69,774,005.8 | −31.3% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/18–05/19 | 05/20 | 235,395 sh39 trades | $224.18avg. | $52,771,862.2 | No record | |
Astera LabsALAB | Open-market sale | 05/18 | 05/20 | 14,076 sh18 trades | $231.78avg. | $3,262,538 | −11.9% | |
Astera LabsALAB | Open-market sale | 05/18 | 05/20 | 95,444 sh17 trades | $225.02avg. | $21,476,901.88 | −6.2% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/07 | 05/11 | 12,499 sh6 trades | $200.03avg. | $2,500,199.2 | No record | |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/07 | 05/11 | 139,951 sh7 trades | $200.17avg. | $28,013,718.93 | −3.4% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 05/07 | 05/11 | 280,000 sh45 trades | $198.39avg. | $55,549,904.75 | −29.9% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/17–04/20 | 04/21 | 24,998 sh6 trades | $175.06avg. | $4,376,257.88 | No record | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/17–04/20 | 04/21 | 335,881 sh10 trades | $172.24avg. | $57,852,407.08 | −7.6% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/15 | 04/16 | 2,967 sh2 trades | $174.60avg. | $518,041.19 | −0.1% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/10 | 04/14 | 123,750 sh2 trades | $149.67avg. | $18,522,140.94 | −2.7% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/01 | 04/03 | 183,000 sh7 trades | $107.61avg. | $19,693,030.72 | −36.4% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 04/01 | 04/03 | 10,000 sh5 trades | $107.76avg. | $1,077,641.9 | −7.8% | |
Astera LabsALAB | Open-market sale10b5-1 plan | 03/17 | 03/19 | 157,500 sh10 trades | $131.58avg. | $20,723,549.67 | −3.4% | |
Lazar Jack R.Director | Astera LabsALAB | Open-market sale10b5-1 plan | 03/16 | 03/17 | 2,500 sh | $130.00 | $325,000 | −2.9% |